高级检索
当前位置: 首页 > 详情页

Predictive markers for severe hypocalcemia in dialysis patients with secondary hyperparathyroidism after near-total parathyroidectomy

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Department of Nephrology, School of Medicine, Sichuan Academy of Medical Science and Sichuan Provincial People’s Hospital, Sichuan ClinicalResearch Center for Kidney Diseases, University of Electronic Science and Technology of China, Chengdu, China [2]Department of Nephrology,China-Japan Friendship Hospital, Beijing, China [3]Department of Nephrology, Suining Central Hospital, Suining, China [4]Department of Breast andThyroid Surgery, China-Japan Friendship Hospital, Beijing, China
出处:
ISSN:

关键词: Severe hypocalcemia (SH) secondary hyperparathyroidism (SHPT) dialysis near-total parathyroidectomy (near-tPTX) alkaline phosphatase (ALP)

摘要:
Background: Secondary hyperparathyroidism (SHPT) is common in dialysis patients with end-stage renal disease (ESRD). Parathyroidectomy (PTX) is an effective treatment for SI WT. Postoperative severe hypocalcemia (SH) is a common and severe complication after PTX. This study aimed to investigate the potential predictive markers of SH in dialysis ESRD patients with SHPT after near-total PTX (near-tPTX) without autotransplantation (AT). Methods: A retrospective analysis involving 131 dialysis patients with SHPT who were treated with near-tPTX without AT between January and August 2018 was performed. Demographic characteristics (age, gender, type of dialysis modality, etc.) and perioperative laboratory parameters [serum calcium, phosphorus, alkaline phosphatase (ALP), intact parathyroid hormone (iPTH), and bone metabolism markers] were collected and analyzed. Postoperative serum calcium level <1.875 mmol/L (7.5 mg/dL) was defined as postoperative SH. Results: Among the 131 patients, 73 (55.7%) had postoperative hypocalcemia and 43 (32.8%) had postoperative SH. Univariate analysis showed that values of preoperative serum iPTH, calcium, ALP, bone-specific alkaline phosphatase (BAP), and osteocalcin (OC) were significantly different between the SH and non-SH groups. In the multivariate logistic regression model, preoperative serum ALP was an independent risk predictor of postoperative SH. The receiver operating characteristic (ROC) curve for preoperative serum ALP was 277 U/L. The sensitivity of preoperative serum ALP was 73.8% and the specificity was 63.2%. Conclusions: The incidence rates of postoperative hypocalcemia and SH in dialysis patients with SHPT after near-tPTX without AT were 55.7% and 32.8%, respectively. Preoperative serum ALP was an independent predictor for the occurrence of postoperative SII, and dialysis patients with SIIPT were susceptible to postoperative SH when preoperative serum ALP level was >277 U/L. Hence, we recommend that preoperative serum ALP be utilized to complement clinical protocols for postoperative SH management of dialysis ESRD patients with SHPT after near-tPTX without AT.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2020]版:
大类 | 2 区 医学
小类 | 2 区 卫生保健与服务
最新[2025]版:
JCR分区:
出版当年[2019]版:
Q3 HEALTH CARE SCIENCES & SERVICES
最新[2023]版:

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2019版] 出版当年五年平均[2015-2019] 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者单位: [1]Department of Nephrology, School of Medicine, Sichuan Academy of Medical Science and Sichuan Provincial People’s Hospital, Sichuan ClinicalResearch Center for Kidney Diseases, University of Electronic Science and Technology of China, Chengdu, China
共同第一作者:
通讯作者:
通讯机构: [1]Department of Nephrology, School of Medicine, Sichuan Academy of Medical Science and Sichuan Provincial People’s Hospital, Sichuan ClinicalResearch Center for Kidney Diseases, University of Electronic Science and Technology of China, Chengdu, China [2]Department of Nephrology,China-Japan Friendship Hospital, Beijing, China [*1]Department of Nephrology, China-Japan Friendship Hospital, No. 2 Yinghua East Street, Chaoyang District, Beijing 100029, China. [*2]Department of Nephrology, School of Medicine, Sichuan Academy of Medical Science and Sichuan Provincial People’s Hospital, Sichuan Clinical Research Center for Kidney Diseases, University of Electronic Science and Technology of China, West 2nd Duan, 1st Circle Rd, Qingyang District, Chengdu 610072, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)